ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD^®) in Asian men with prostate cancer

Rohan Malek, Sheng-Tang Wu, Dennis Serrano, Tran Tho, Rainy Umbas, Jeremy Teoh, Bannakji Lojanapiwat, Teng Aik Ong, Weber Kam On, Sam Minh Thai, Janet Kim, Rupesh Pophale, Edmund Chiong